Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10962098 | Tuberculosis | 2013 | 7 Pages |
Abstract
These preliminary results suggest that combinations of serodiagnostic markers measured prior to initiation of treatment may be suitable for the prediction of early treatment response. This approach holds promise and requires further evaluation for its utility in the prediction of treatment failure and relapse, the evaluation of new TB therapeutics, as well as in the care of individual patients.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Ralf Baumann, Susanne Kaempfer, Novel N. Chegou, Nonhlanhla F. Nene, Hanne Veenstra, Ralf Spallek, Chris T. Bolliger, Pauline T. Lukey, Paul D. van Helden, Mahavir Singh, Gerhard Walzl,